2 hours ago
Psychedelic Drug Stocks Explode After Trump’s FDA Fast-Track Executive Order
Trump executive order accelerates psychedelic drug approvals. AtaiBeckley surges 28%, Compass Pathways up 26% as FDA review times cut to 1-2 months.
The post Psychedelic Drug Stocks Explode After Trump’s FDA Fast-Track Executive Order appeared first on Blockonomi.
Source: Blockonomi →Related News
- 45 minutes ago
COMPASS Pathways (CMPS) Stock Soars 25% on Trump’s Psychedelics Research Order
- 1 hour ago
5 Leading Cloud Infrastructure Stocks on Analysts’ Radars for 2026
- 1 hour ago
Rocket Lab (RKLB) Stock: Wall Street Analysts Raise Price Targets Amid Mynaric A...
- 1 hour ago
Robinhood (HOOD) Stock Climbs as Mizuho Boosts Price Target to $115 on Regulator...
- 1 hour ago
Definium Therapeutics (DFTX) Stock Soars to New Heights on Trump’s Psychedelic R...